Glipizide |
Glucotrol |
Glipizide Systematic (IUPAC) name N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]- 5-methyl-pyridine-2-carboxamide Identifiers CAS number 29094-61-9 ATC code A10BB07 PubChem 3478 DrugBank APRD00436 Chemical data Formula C21H27N5O4S Mol. weight 445.536 g/mol Pharmacokinetic data Bioavailability 100% (regular formulation) 90% (extended release) Protein binding 98 to 99% Metabolism Hepatic hydroxylation Half life 2 to 5 hours Excretion Renal and ...
Wikipedia - [full article]
Glipizide Clinical Trials
- Rosiglitazone versus Glipizide on Progression of Atherosclerosis in Patients with Cardiovascular Disease and Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00116831 - Recruiting
Non-Insulin-Dependent Diabetes Mellitus
- Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
ClinicalTrials.gov Identifier: NCT00509262 - Recruiting
Type 2 Diabetes Mellitus; Renal Insufficiency, Chronic
- Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease
ClinicalTrials.gov Identifier: NCT00509236 - Recruiting
Type 2 Diabetes Mellitus; Renal Disease, End-Stage
- MK0767 Glipizide Comparator Cardiac Safety Study
ClinicalTrials.gov Identifier: NCT00543010 - Completed
Diabetes Mellitus, Type 2

Not Signed In -

